| Trial ID: | L6381 |
| Source ID: | NCT01638988
|
| Associated Drug: |
Metformin
|
| Title: |
Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Polycystic Ovary Syndrome|Insulin Resistance
|
| Interventions: |
DRUG: Metformin|DRUG: Clomiphene citrate
|
| Outcome Measures: |
Primary: Biochemical pregnancy, Rate of biochemical pregnancy, 1 month | Secondary: Ovulation rate, Ovulation rate, 1 month|Live birth rate, 6 months|Spontaneous abortion rate, 6 months|BMI and waist size changing, 6 months|Insulin resistance changing, 6 months|AMH correlation/variation in function of Metformin, 6 months
|
| Sponsor/Collaborators: |
Sponsor: Clinique Ovo
|
| Gender: |
FEMALE
|
| Age: |
ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-09
|
| Completion Date: |
2015-12
|
| Results First Posted: |
|
| Last Update Posted: |
2015-07-28
|
| Locations: |
Clinique Ovo, Montréal, Quebec, H4P 2S4, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT01638988
|
